Ototoxicity Completed Phase 2 Trials for Methotrexate (DB00563)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01848457Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma TherapySupportive Care